Skip to Content
Merck
  • DBT- and DBTO2-induced dysplasia and their associated proteomic alterations in the small intestines of Wistar rats.

DBT- and DBTO2-induced dysplasia and their associated proteomic alterations in the small intestines of Wistar rats.

Journal of proteome research (2014-11-05)
Karina Taciana Silva, Renata Alves Oliveira-Castro, Vinícius Correa Rodrigues, Wanderson Geraldo de Lima, Cibele Velloso Rodrigues, William Castro-Borges, Milton Hércules Guerra Andrade
ABSTRACT

Dibenzothiophene (DBT) and its oxidized derivative dibenzothiophene sulfone (DBTO2) are important representatives of polycyclic aromatic hydrocarbons (PAHs). Due to the importance of PAHs in oncogenesis and the lack of toxicological investigations related to DBT and DBTO2, this work proposes to assess their toxic and molecular effects caused by chronic treatment of Wistar rats. In parallel, their effects were compared to those caused by treatment with 1,2-dimethylhydrazine (DMH), a classic mutagenic agent. At the 14th day post-treatment, the animals were sacrificed and blood withdrawn for hematology and evaluation of liver and pancreatic functions. No significant alterations were observed. Nevertheless, histopathological analyses revealed dysplastic lesions in the intestines of animals treated with DBT and DBTO2. CD44 and carcinoembryonic antigen (CEA) staining demonstrated an approximately 3-fold increase in expression of both tissue markers for animals administered DBT, DBTO2, and DMH. A comparative two-dimensional gel analysis revealed additional 23 proteins exhibiting altered levels in the small intestines caused by exposure to DBT and DBTO2. At last, a protein-metabolite interaction map provided major insights into the metabolism of the dysplastic tissues. Our results provided strong evidence that DBT and its derivative could potentially act as cancer inducers, highlighting their toxicological and environmental relevance.

MATERIALS
Product Number
Brand
Product Description

Supelco
Dibenzothiophene, analytical standard
Sigma-Aldrich
Urea solution, BioUltra, ~8 M in H2O
Supelco
Ethanol solution, certified reference material, 2000 μg/mL in methanol
Sigma-Aldrich
Ammonium-14N2,sulfate-16O4, 99.99 atom % 16O, 99.99 atom % 14N
Sigma-Aldrich
Urea-12C, 99.9 atom % 12C
Sigma-Aldrich
5,5-Dimethylhydantoin, 97%
Sigma-Aldrich
Dibenzothiophene, ≥99%
Sigma-Aldrich
Ammonium-14N2 sulfate solution, 40 wt. % in H2O, 99.99 atom % 14N
Sigma-Aldrich
Ammonium sulfate-14N2 solution, 40 wt. % in H2O, 99.99 atom % 14N
Sigma-Aldrich
3-[(3-Cholamidopropyl)dimethylammonio]-1-propanesulfonate hydrate, 98%
Sigma-Aldrich
Thiourea, ACS reagent, ≥99.0%
Sigma-Aldrich
Thiourea, ReagentPlus®, ≥99.0%
Sigma-Aldrich
Urea solution, 40 % (w/v) in H2O
Millipore
Urea solution, suitable for microbiology, 40% in H2O
Sigma-Aldrich
Dibenzothiophene, 98%
Supelco
Dehydrated Alcohol, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Phosphoric acid solution, NMR reference standard, 85% in D2O (99.9 atom % D), NMR tube size 3 mm × 8 in.
Sigma-Aldrich
Phosphoric acid solution, NMR reference standard, 85% in D2O (99.9 atom % D), NMR tube size 5 mm × 8 in.
Sigma-Aldrich
Phosphoric acid solution, NMR reference standard, 85% in D2O (99.9 atom % D), NMR tube size 4.2 mm × 8 in. , WGS-5BL Coaxial NMR tube
Sigma-Aldrich
Phosphoric acid solution, 85 wt. % in H2O, FCC, FG
USP
Dehydrated Alcohol, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Ethanol, tested according to Ph. Eur.
Sigma-Aldrich
Ethyl alcohol, Pure, 190 proof, ACS spectrophotometric grade, 95.0%
Sigma-Aldrich
Ammonium-14N2 sulfate, 99.99 atom % 14N
Sigma-Aldrich
Ammonium sulfate, 99.999% trace metals basis
Supelco
p-Toluidine, for spectrophotometric det. of Au, Tl(III), W, ≥99.0%
Sigma-Aldrich
Urea, BioUltra, for molecular biology, 99% (T)
Sigma-Aldrich
Ethanol, for residue analysis
Sigma-Aldrich
Bromophenol Blue, ACS reagent
Sigma-Aldrich
p-Toluidine, 99%